CN102940874B - 小分子多肽cw14在制备山羊抗菌药物中的应用 - Google Patents

小分子多肽cw14在制备山羊抗菌药物中的应用 Download PDF

Info

Publication number
CN102940874B
CN102940874B CN 201210533946 CN201210533946A CN102940874B CN 102940874 B CN102940874 B CN 102940874B CN 201210533946 CN201210533946 CN 201210533946 CN 201210533946 A CN201210533946 A CN 201210533946A CN 102940874 B CN102940874 B CN 102940874B
Authority
CN
China
Prior art keywords
goat
preparation
application
small molecular
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201210533946
Other languages
English (en)
Other versions
CN102940874A (zh
Inventor
赖仞
容明强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Institute of Zoology of CAS
Original Assignee
Kunming Institute of Zoology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Institute of Zoology of CAS filed Critical Kunming Institute of Zoology of CAS
Priority to CN 201210533946 priority Critical patent/CN102940874B/zh
Publication of CN102940874A publication Critical patent/CN102940874A/zh
Application granted granted Critical
Publication of CN102940874B publication Critical patent/CN102940874B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明涉及小分子多肽CW14在制备山羊抗菌药物中的应用，属于多肽技术领域。分子量为1515.75 Da,等电点为 9.52，氨基酸序列为AGAKCYKKVG RDGY的小分子多肽CW14在制备山羊抗菌药物中的应用。本发明的效果在于：用小分子多肽CW14制备的山羊抗菌药物，抑菌效果明显。

Description

小分子多肽CW14在制备山羊抗菌药物中的应用
技术领域：
本发明涉及小分子多肽CW14在制备山羊抗菌药物中的应用，属于多肽技术领域。
背景技术：
抗生素的广泛应用,耐药菌株和多重耐药菌株日益增加,临床抗感染治疗已面临严峻挑战,寻找广谱高效的抗细菌、抗病毒药物,仍然是一个十分艰巨的任务。抗菌肽是动物体内极为重要的先天免疫物质，是一种具有高效抗菌、抗病毒、免疫功能的生物活性因子。抗菌肽是宿主非特异性免疫防御系统产生的一类对抗外源性病原体的肽类活性物质，是天然免疫的效应分子。研究表明，抗菌肽有着与传统抗生素完全不同的作用机制，不易诱导耐药菌株的产生；抗菌谱广，对细菌、真菌、病毒、原虫及癌细胞均有作用。在家禽上，已经发现了3个家族的抗菌肽包括cathelicidin, liver-expressed antimicrobial peptide (LEAP), and β-defensin。 这些抗菌肽对于家禽抵抗细菌性、病毒性疾病具有至关重要的作用。相关这些基因的突变或者缺失对于家禽抗微生物感染的能力将有显著的影响。这些些抗菌肽除了具有广谱抗菌活性，同时还有高效的抗真菌、抗病毒、抗原虫和（或）抗肿瘤活性，如Bat5和IMc7能杀灭钩端螺旋体，对白色念珠菌、隐球菌和包膜病毒和寄生虫都有较好的杀灭作用；一些抗菌肽对疱疹病毒、流感病毒、艾滋病病毒等有囊膜病毒有明显的杀伤力。此外，有些抗菌肽同时还具有多种其他的调控功能，如Cathelicidin还具有促进伤口愈合、组织损伤修复、化学趋化作用、促血管生成和抗寄生虫等功能，在调节动物机体免疫上有着重要生物学活性。
发明内容：
本发明的目的在于提供小分子多肽CW14在制备山羊抗菌药物中的应用。
本发明的所用的小分子多肽CW14采用常规的化学合成的方法获得，小分子多肽CW14的分子量为1515.75 Da,等电点为 9.52，氨基酸序列为AGAKCYKKVG RDGY。该小分子多肽CW14在制备山羊抗菌药物中的应用。
小分子多肽CW14的抗菌试验，其试验方案为常规方法，具体如下：
将已制备好的高柱肉汤琼脂培养基加热熔化后,待冷却至50℃左右时,加入肉汤培养基菌液1mL(经过恒温37℃培养18小时的菌液),轻轻摇动,使之均匀.然后倒入无菌的平皿内,轻轻晃动平皿,以使培养基均匀地平铺在平皿上,待冷却凝固后,用消毒过的镊子将青霉素干纸片、链霉素干纸片、四环素干纸片、磺胺嘧啶干纸片整齐有顺序的放入平血内,盖上陶瓦盖,标好记号置37℃恒温培养箱内培养24小时.24小时后取出培养基,用卡尺量取抑菌圈大小并记录之,并比较不同抗菌药物对不同细菌的作用强度。
本发明的效果在于：用小分子多肽CW14制备的山羊抗菌药物，抑菌效果明显。
附图说明：
图1是山羊小分子多肽CW14对金色葡萄球菌的抑制效果。
具体实施方式：
下面结合附图对本发明作进一步的详细说明。
实施例所用的小分子多肽CW14采用常规的化学合成的方法获得，小分子多肽CW14的分子量为1515.75 Da,等电点为 9.52，氨基酸序列为AGAKCYKKVG RDGY。
小分子多肽CW14的抗菌试验，具体步骤同发明内容部分的描述。
实施例1 ：
小分子多肽CW14对金色葡萄球菌的抑制作用。
取8μg/ml、以及12μg/ml山羊小分子多肽CW14进行抑菌试验。结果为：8ug/ml山羊小分子多肽CW14仅有较弱的抑菌效果（图1-B），12ug/ml山羊小分子多肽CW14抑菌效果很明显（图1-C）,图1-A为山羊小分子多肽CW14抑菌效果试验对照。
实施例2 ：
小分子多肽CW14对不同微生物的最低抑菌浓度。
取不同浓度的山羊小分子多肽CW14分别抑制大肠杆菌、绿脓杆菌、金色葡萄球菌，枯草杆菌以及白色念珠菌。其中表1表示该多肽对大肠杆菌、绿脓杆菌、金色葡萄球菌，枯草杆菌以及白色念珠菌的最低抑制浓度分别为：11.45 μg/ml，18.34μg/ml，6.91μg/ml，15.54 μg/ml，22.67 μg/ml。
表1
Figure BDA0000257133451
SEQUENCE LISTING
 
<110>  中国科学院昆明动物研究所
 
<120> 小分子多肽CW14在制备山羊抗菌药物中的应用
 
<130>  1
 
<160>  1    
 
<170>  PatentIn version 3.3
 
<210>  1
<211>  14
<212>  PRT
<213>  Capra ibex
 
<400>  1
 
Ala Gly Ala Lys Cys Tyr Lys Lys Val Gly Arg Asp Gly Tyr
1               5                   10                 
 
 

Claims (1)

1.分子量为1515.75Da，等电点为9.52，氨基酸序列为AGAKCYKKVGRDGY的小分子多肽CW14在制备对大肠杆菌、绿脓杆菌、金色葡萄球菌，枯草杆菌以及白色念珠菌具有抑菌作用试剂中的应用。
CN 201210533946 2012-12-12 2012-12-12 小分子多肽cw14在制备山羊抗菌药物中的应用 Expired - Fee Related CN102940874B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210533946 CN102940874B (zh) 2012-12-12 2012-12-12 小分子多肽cw14在制备山羊抗菌药物中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210533946 CN102940874B (zh) 2012-12-12 2012-12-12 小分子多肽cw14在制备山羊抗菌药物中的应用

Publications (2)

Publication Number Publication Date
CN102940874A CN102940874A (zh) 2013-02-27
CN102940874B true CN102940874B (zh) 2013-12-18

Family

ID=47723934

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210533946 Expired - Fee Related CN102940874B (zh) 2012-12-12 2012-12-12 小分子多肽cw14在制备山羊抗菌药物中的应用

Country Status (1)

Country Link
CN (1) CN102940874B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801670B (zh) * 2014-05-30 2019-05-17 四川大学 具抗菌活性的多肽及其应用
BR112016030580B1 (pt) 2014-06-26 2023-12-19 The Rockefeller University Polipeptídeo de lisina e fragmento de polipeptídeo com atividade para matar bactérias gram-negativas

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1704431A (zh) * 2004-06-04 2005-12-07 中国人民解放军第三军医大学第一附属医院 蜂毒肽及其应用
CN102603883A (zh) * 2011-01-24 2012-07-25 中国科学院动物研究所 一种抗菌肽、其制备方法和用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1704431A (zh) * 2004-06-04 2005-12-07 中国人民解放军第三军医大学第一附属医院 蜂毒肽及其应用
CN102603883A (zh) * 2011-01-24 2012-07-25 中国科学院动物研究所 一种抗菌肽、其制备方法和用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A peptide based on the pore-forming domain of pro-apoptotic poliovirus 2B viroporin targets mitochondria;Vanesa et al;《Biochimica et Biophysica Acta》;20101231;52–58 *
Vanesa et al.A peptide based on the pore-forming domain of pro-apoptotic poliovirus 2B viroporin targets mitochondria.《Biochimica et Biophysica Acta》.2010,52–58.

Also Published As

Publication number Publication date
CN102940874A (zh) 2013-02-27

Similar Documents

Publication Publication Date Title
Menousek et al. Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300
Mohamed et al. Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides
Findlay et al. Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold
Garcia et al. Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics
JP7267251B2 (ja) 抗菌組成物及び医薬組成物
CN102702333B (zh) 抗耐药性病原菌感染多肽及其用途
KR20040002880A (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
Li et al. An enhanced variant designed from DLP4 cationic peptide against Staphylococcus aureus CVCC 546
Underwood et al. Innate immunity and the role of defensins in otitis media
Cao et al. Killing Streptococcus mutans in mature biofilm with a combination of antimicrobial and antibiofilm peptides
Nguyen et al. Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
Gogoi et al. Linear and branched forms of short antimicrobial peptide-IRK inhibit growth of multi drug resistant Staphylococcus aureus isolates from mastitic cow milk
Teixeira et al. In vivo antimicrobial evaluation of an alanine-rich peptide derived from Pleuronectes americanus
O'Neill et al. Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius
Rodrigues et al. Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence
CN102940874B (zh) 小分子多肽cw14在制备山羊抗菌药物中的应用
Rangel et al. An update on the therapeutic potential of antimicrobial peptides against Acinetobacter baumannii infections
Vineethkumar et al. Post-translationally modified frog skin-derived antimicrobial peptides are effective against Aeromonas sobria
Kim et al. Effects of the synthetic coprisin analog peptide, CopA3 in pathogenic microorganisms and mammalian cancer cells
CN104524547B (zh) 菌丝霉素在抑制无乳链球菌中的应用
Wu et al. Protective effects of antimicrobial peptide S-thanatin against endotoxic shock in mice introduced by LPS
CN102940877B (zh) 多肽dm29在制备增加山羊天然免疫功能药物中的应用
CN102935223B (zh) 多肽gc25在制备治疗抗感染药物中的应用
CN102940876B (zh) 多肽gh27在制备预防及治疗山羊腹泻药物中的应用
Yuan et al. In vitro and in vivo antibacterial activity of a lysine-rich scorpion peptide derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131218

Termination date: 20141212

EXPY Termination of patent right or utility model